New episodes processed by Podwise, ready to search, skim and continue in the full app.
Read what each episode covers before you press play.
AI summary Manus 的发展历程折射出 AI 创业公司在复杂地缘政治与监管博弈中的生存困境。作为一家 AI Agent 产品公司，Manus 在获得硅谷风投 Benchmark 投资后，迅速遭遇美国 “反向 CFIUS” 审查，被迫将总部迁至新加坡以规避风险。随后，Meta 对其发起的收购引发了中国商务部关于技术出口的国家安全审查，最终导致交易撤销并由中资机构回购。这一系列跌宕起伏的资本运作与监管干预，不仅揭示了中美科技竞赛下 “科技回流” 的政策暗线，也为寻求全球化发展的创业者提供了关于政治敏感性与合规边界的深刻警示。Manus 的经历证明，在 AI…
45 minChineseSummary · Transcript
AI summary Artificial intelligence is evolving into a potential "global brain," a superintelligence that may eventually possess governing authority. This technological shift demands a new, cohesive international framework to manage existential risks, such as the development of bioweapons…
00:51:31EnglishSummary · Transcript
AI summary Data center development faces a significant disconnect between projected capacity and actual infrastructure delivery, driven by speculative "large load" queues that often overestimate realistic build-outs by an order of magnitude. While hyperscalers and AI firms scramble for…
33 minEnglishSummary · Transcript
AI summary 艾伯维通过精密的专利丛林构建、诉讼和解及 PBM 反点机制，成功化解了 “药王” 修美乐专利到期带来的巨大冲击。在核心产品面临专利悬崖时，公司利用深厚的现金流优势，通过并购利生奇珠单抗和乌帕替尼等临床后期资产，迅速完成了第二增长曲线的接棒。这种以现金流为驱动的商业模式，通过优化给药方式和拓展适应症，将新药迅速推向百亿销售规模。艾伯维的成功不仅在于分子的选择，更在于其强大的组织执行力，即在旧产品盈利期内主动完成处方转移，并利用医美与神经科学业务的稳定性对冲免疫领域的周期性风险，展现了跨国药企在专利生命周期管理中的极致策略。
01:03:35ChineseSummary · Transcript
AI summary Harvard-trained physician and medical scientist Dr. William Li explores the revolutionary intersection of nutrition and disease prevention, specifically focusing on how food can "starve" cancer and bolster the body's innate health defense systems. While the human body naturally…
02:06:40EnglishSummary · Transcript
AI summary MiniMax, a Chinese AI firm, differentiates itself from Silicon Valley's resource-rich labs by prioritizing computational efficiency and open-source collaboration. Founder and CEO Yan Junjie (Io) defines AGI as the point where AI drives scientific breakthroughs and develops new…
12:55EnglishSummary · Transcript
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
The Journal.
Follow your shows in Podwise and read each new episode before you decide to listen.
